X 
0.26
-3.77%
Close of 9 Nov 2026, in HKD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
At a glance
Figures in CNY, from our data supplier.
Revenue
CN¥1.55bn
FY2020FY2025
Net income
CN¥45.9m
FY2020FY2025
Free cash flow
−CN¥530.4m
FY2020FY2025
Shareholders' equity
CN¥872.6m
FY2020FY2025
Income statement
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Revenue | CN¥1.55bn | CN¥996.5m | CN¥863.5m | CN¥751.5m | CN¥936.7m | CN¥515.1m |
| Research and development | CN¥10.8m | CN¥9.8m | CN¥10.2m | CN¥11.4m | CN¥13.9m | CN¥9.1m |
| Operating income | CN¥229.4m | CN¥181.4m | CN¥249.1m | CN¥162.1m | CN¥160.8m | CN¥130.1m |
| Net income | CN¥45.9m | CN¥34.2m | CN¥94.3m | CN¥67.5m | CN¥34.1m | CN¥12.3m |
| Diluted earnings per share | 0.03 | 0.02 | 0.20 | 0.15 | 0.02 | 0.01 |
Balance sheet
At each fiscal year end
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Total assets | CN¥3.83bn | CN¥3.31bn | CN¥2.50bn | CN¥2.22bn | CN¥1.88bn | CN¥1.90bn |
| Cash and short-term investments | CN¥375.9m | CN¥340.6m | CN¥245.3m | CN¥187.7m | CN¥88.6m | CN¥25.3m |
| Total liabilities | CN¥2.95bn | CN¥2.48bn | CN¥1.83bn | CN¥1.79bn | CN¥1.50bn | CN¥1.49bn |
| Debt | CN¥2.80bn | CN¥2.29bn | CN¥1.61bn | CN¥1.48bn | CN¥1.19bn | CN¥1.18bn |
| Shareholders' equity | CN¥872.6m | CN¥822.1m | CN¥663.0m | CN¥427.7m | CN¥372.1m | CN¥396.5m |
| Shares outstanding | 1,630m | 1,621m | 475m | 436m | 1,716m | 1,716m |
Cash flow
Fiscal years
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | |
|---|---|---|---|---|---|---|
| Cash from operations | −CN¥310.6m | −CN¥160.8m | CN¥1.1m | −CN¥63.3m | −CN¥77.4m | CN¥229.9m |
| Capital spending | −CN¥219.8m | −CN¥123.7m | −CN¥174.8m | −CN¥127.5m | −CN¥57.1m | −CN¥180.0m |
| Free cash flow | −CN¥530.4m | −CN¥284.5m | −CN¥173.7m | −CN¥190.8m | −CN¥134.5m | CN¥49.9m |
| Dividends paid | — | −CN¥2.9m | — | — | −CN¥6.3m | −CN¥232.8m |
Latest quarters
By quarter end
| Jun 2026 | Dec 2025 | Jun 2025 | Dec 2024 | Sept 2024 | Jun 2024 | Mar 2024 | Dec 2023 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | CN¥750.8m | CN¥939.5m | CN¥613.1m | CN¥565.4m | CN¥330.7m | CN¥431.1m | CN¥252.4m | CN¥476.4m |
| Operating income | CN¥98.6m | CN¥114.8m | CN¥114.8m | CN¥89.3m | CN¥52.2m | CN¥92.1m | CN¥53.9m | CN¥123.2m |
| Net income | CN¥17.3m | CN¥23.4m | CN¥22.5m | CN¥17.3m | CN¥10.1m | CN¥16.8m | CN¥9.9m | CN¥40.9m |
| Diluted earnings per share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.09 |
| Cash from operations | CN¥171.0m | −CN¥271.0m | −CN¥30.0m | −CN¥83.0m | — | CN¥3.0m | CN¥3.0m | −CN¥2.0m |
| Capital spending | −CN¥41.0m | −CN¥74.0m | −CN¥135.0m | −CN¥2.0m | — | −CN¥69.0m | −CN¥69.0m | −CN¥4.0m |
| Free cash flow | CN¥130.0m | −CN¥345.0m | −CN¥165.0m | −CN¥85.0m | — | −CN¥66.0m | −CN¥66.0m | −CN¥6.0m |
| Total assets | CN¥3.90bn | CN¥3.83bn | CN¥3.41bn | CN¥3.31bn | CN¥3.31bn | CN¥2.52bn | CN¥2.94bn | CN¥2.50bn |
| Cash and short-term investments | CN¥450.0m | CN¥375.9m | CN¥333.8m | CN¥340.6m | CN¥340.6m | CN¥212.3m | CN¥248.3m | CN¥245.3m |
| Debt | CN¥1.29bn | CN¥2.80bn | CN¥2.45bn | CN¥2.29bn | CN¥1.16bn | CN¥1.71bn | CN¥964.6m | CN¥1.61bn |
| Shareholders' equity | CN¥1.13bn | CN¥872.6m | CN¥846.5m | CN¥822.1m | CN¥822.1m | CN¥682.2m | CN¥798.0m | CN¥663.0m |
Financial ratios
Data as of 31 Oct 2026
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | |
|---|---|---|---|---|---|---|---|
| Operating margin | 15.2% | 18.5% | 19.7% | 21.6% | 17.9% | 22.3% | — |
| Net margin | 3.0% | 3.4% | 10.9% | 9.0% | 3.6% | 2.4% | — |
| Return on equity | 5.3% | 4.9% | 14.2% | 15.8% | 7.8% | 3.1% | — |
| Return on assets | 1.2% | 1.2% | 3.8% | 3.0% | 1.5% | 0.7% | — |
| Free cash flow yield | -21.9% | -10.5% | 169.9% | 67.6% | — | — | — |
| Revenue growth | 33.2% | 15.4% | 14.9% | -6.2% | 81.9% | — | — |
| Earnings growth | 14.7% | -63.7% | 39.7% | 131.3% | 176.4% | — | — |
| Current ratio | 1.23x | 1.24x | 1.23x | 1.03x | 0.87x | 0.93x | — |
| Debt to equity | 3.21x | 2.78x | 2.41x | 3.44x | 3.19x | 1.80x | — |
| Equity ratio | 22.8% | 24.8% | 26.5% | 19.2% | 19.8% | 20.9% | — |
| Interest coverage | 1.40x | 1.34x | 1.22x | 1.32x | 1.40x | 1.03x | — |
| R&D as a share of sales | 0.7% | 1.0% | 1.2% | 1.5% | 1.5% | 1.8% | — |
| Buybacks as a share of market value | -0.5% | -241.1% | -9.0% | -14.2% | — | — | 0.0% |
Growth per year
Compound annual rate
| 3 years | 5 years | 10 years | |
|---|---|---|---|
| Revenue | 27.4% | 24.7% | — |
| Operating income | 12.3% | 12.0% | — |
| Net income | -12.1% | 30.0% | — |
Average margins
Over each period
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| Operating margin | 16.1% | 19.7% | 19.8% | — |
| Net margin | 3.1% | 5.8% | 5.1% | — |
Valuation history
At each fiscal year end
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Price to earnings | 65.8 | 49.1 | 0.8 |
| Price to sales | 1.9 | 1.7 | 0.1 |
Dividends and splits
Per share, in the currency the company pays
Paid for 0 years.
- 3-for-1 split · 5 Dec 2024
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.